NEW REPORT: Oncology Partnering Agreements in Pharma, Biotech and Diagnostics

Providing detailed understanding and analysis of how and why companies enter oncology partnering deals, plus access to actual oncology agreements order here now

REVISED AND UPDATED: Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

CurrentPartnering’s Practical Guide to Finding Partners in Pharma & Biotech provides a comprehensive overview of all the steps required to identify and secure partnering either for an in-licensing or out-licensing activity order here today

JUST PUBLISHED: Option & Evaluation Agreements in Pharma and Biotech

Providing detailed understanding and analysis of how and why companies enter option and evaluation deals, plus access to actual option and evaluation agreements order now here

JUST PUBLISHED: Royalty Financing Agreements in Pharma, Biotech and Diagnostics

Providing detailed understanding and analysis of how and why companies enter royalty financing deals, plus access to actual royalty financing agreements order here

Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 2nd edition

Providing detailed understanding and analysis of how and why companies enter co-promotion and co-marketing deals, plus access to actual agreements Co-promotion and Co-marketing Agreements in Biopharma

Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 2nd edition

Providing detailed understanding and analysis of how and why companies enter M&A deals, plus access to actual M&A agreements Merger and Acquisition Agreements in Biopharma

Product and Asset Purchase Agreements in Pharm, Biotech & Diagnostics

Providing detailed understanding and analysis of how and why companies enter asset purchase deals, plus 100s of asset purchase agreements order now

Other reports from CurrentPartnering

Plus 100s of other reports and books on partnering best practice available and updated weekly Browse reports

In the news: Partnering starts to gain momentum

Recent deals include Watson Pharmaceuticals to acquire privately held Arrow Group for $1.75 billion in cash and stock; Akorn acquires Capastat sulfate from Eli Lilly; Penwest enters third R&D agreement with Otsuka - more news

PanGenerika: A Gateway to Europe’s Pharmaceuticals Markets

PanGenerika is a company that was created and registered in the Netherlands in June 2007 with the intention of easing the burden on pharmaceutical companies that want to enter the European market- read now

Collecting Payments Even If Your Patent Application Never Issues as a Patent

This article introduces what should be considered in negotiating license agreements with pending patent application. It recommends the licensor to insert a de-escalating royalty clause and a clause regarding the “know-how” information to be protected from the uncertainty of the patent prosecution process more articles

Partnering events for summer/fall 2009

Next up: Euro-Biotech Forum 2009; BioPharm America 2009; Pharmaceutical Strategic Alliances 2009; EuroBio 2009; 9th MedTech Investing Europe Conference; BioNetwork 2009 more events

People on the move

Updated daily to provide the latest on career moves during the spring/summer 2009 career updates

The best of the web for dealmakers

The best partnering resources available online - from software tools to partnering quotes to reference library View resources